The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Endocrine System Drugs Market Research Report 2025
Synopsis
The global Endocrine System Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Endocrine System Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Endocrine System Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Endocrine System Drugs include Novo Nordisk, Sanofi, Merck, Eli Lilly, AstraZeneca and AbbVie, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Endocrine System Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocrine System Drugs.
Report Scope
The Endocrine System Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Endocrine System Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endocrine System Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Sanofi
Merck
Eli Lilly
AstraZeneca
AbbVie
Segment by Type
Diabetes Drug
Human Growth Hormones
Thyroid Hormone Disorder Drugs
Others
Segment by Application
Hospitals
Clinics
Medical Center
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Endocrine System Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Endocrine System Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Endocrine System Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Endocrine System Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Endocrine System Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Endocrine System Drugs include Novo Nordisk, Sanofi, Merck, Eli Lilly, AstraZeneca and AbbVie, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Endocrine System Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocrine System Drugs.
Report Scope
The Endocrine System Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Endocrine System Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endocrine System Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Sanofi
Merck
Eli Lilly
AstraZeneca
AbbVie
Segment by Type
Diabetes Drug
Human Growth Hormones
Thyroid Hormone Disorder Drugs
Others
Segment by Application
Hospitals
Clinics
Medical Center
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Endocrine System Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Endocrine System Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Endocrine System Drugs Market Overview
1.1 Product Overview and Scope of Endocrine System Drugs
1.2 Endocrine System Drugs Segment by Type
1.2.1 Global Endocrine System Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Diabetes Drug
1.2.3 Human Growth Hormones
1.2.4 Thyroid Hormone Disorder Drugs
1.2.5 Others
1.3 Endocrine System Drugs Segment by Application
1.3.1 Global Endocrine System Drugs Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Medical Center
1.3.5 Others
1.4 Global Endocrine System Drugs Market Size Estimates and Forecasts
1.4.1 Global Endocrine System Drugs Revenue 2019-2030
1.4.2 Global Endocrine System Drugs Sales 2019-2030
1.4.3 Global Endocrine System Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Endocrine System Drugs Market Competition by Manufacturers
2.1 Global Endocrine System Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Endocrine System Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Endocrine System Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Endocrine System Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Endocrine System Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Endocrine System Drugs, Product Type & Application
2.7 Endocrine System Drugs Market Competitive Situation and Trends
2.7.1 Endocrine System Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Endocrine System Drugs Players Market Share by Revenue
2.7.3 Global Endocrine System Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Endocrine System Drugs Retrospective Market Scenario by Region
3.1 Global Endocrine System Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Endocrine System Drugs Global Endocrine System Drugs Sales by Region: 2019-2030
3.2.1 Global Endocrine System Drugs Sales by Region: 2019-2024
3.2.2 Global Endocrine System Drugs Sales by Region: 2025-2030
3.3 Global Endocrine System Drugs Global Endocrine System Drugs Revenue by Region: 2019-2030
3.3.1 Global Endocrine System Drugs Revenue by Region: 2019-2024
3.3.2 Global Endocrine System Drugs Revenue by Region: 2025-2030
3.4 North America Endocrine System Drugs Market Facts & Figures by Country
3.4.1 North America Endocrine System Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Endocrine System Drugs Sales by Country (2019-2030)
3.4.3 North America Endocrine System Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Endocrine System Drugs Market Facts & Figures by Country
3.5.1 Europe Endocrine System Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Endocrine System Drugs Sales by Country (2019-2030)
3.5.3 Europe Endocrine System Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Endocrine System Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Endocrine System Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Endocrine System Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Endocrine System Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Endocrine System Drugs Market Facts & Figures by Country
3.7.1 Latin America Endocrine System Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Endocrine System Drugs Sales by Country (2019-2030)
3.7.3 Latin America Endocrine System Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Endocrine System Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Endocrine System Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Endocrine System Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Endocrine System Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Endocrine System Drugs Sales by Type (2019-2030)
4.1.1 Global Endocrine System Drugs Sales by Type (2019-2024)
4.1.2 Global Endocrine System Drugs Sales by Type (2025-2030)
4.1.3 Global Endocrine System Drugs Sales Market Share by Type (2019-2030)
4.2 Global Endocrine System Drugs Revenue by Type (2019-2030)
4.2.1 Global Endocrine System Drugs Revenue by Type (2019-2024)
4.2.2 Global Endocrine System Drugs Revenue by Type (2025-2030)
4.2.3 Global Endocrine System Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Endocrine System Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Endocrine System Drugs Sales by Application (2019-2030)
5.1.1 Global Endocrine System Drugs Sales by Application (2019-2024)
5.1.2 Global Endocrine System Drugs Sales by Application (2025-2030)
5.1.3 Global Endocrine System Drugs Sales Market Share by Application (2019-2030)
5.2 Global Endocrine System Drugs Revenue by Application (2019-2030)
5.2.1 Global Endocrine System Drugs Revenue by Application (2019-2024)
5.2.2 Global Endocrine System Drugs Revenue by Application (2025-2030)
5.2.3 Global Endocrine System Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Endocrine System Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Endocrine System Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk Endocrine System Drugs Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Endocrine System Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Endocrine System Drugs Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Endocrine System Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Endocrine System Drugs Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Corporation Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Endocrine System Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Lilly Endocrine System Drugs Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Endocrine System Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AstraZeneca Endocrine System Drugs Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 AbbVie
6.6.1 AbbVie Corporation Information
6.6.2 AbbVie Description and Business Overview
6.6.3 AbbVie Endocrine System Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AbbVie Endocrine System Drugs Product Portfolio
6.6.5 AbbVie Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Endocrine System Drugs Industry Chain Analysis
7.2 Endocrine System Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Endocrine System Drugs Production Mode & Process
7.4 Endocrine System Drugs Sales and Marketing
7.4.1 Endocrine System Drugs Sales Channels
7.4.2 Endocrine System Drugs Distributors
7.5 Endocrine System Drugs Customers
8 Endocrine System Drugs Market Dynamics
8.1 Endocrine System Drugs Industry Trends
8.2 Endocrine System Drugs Market Drivers
8.3 Endocrine System Drugs Market Challenges
8.4 Endocrine System Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Endocrine System Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Endocrine System Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Endocrine System Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Endocrine System Drugs Sales (K Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Endocrine System Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Endocrine System Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Endocrine System Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Endocrine System Drugs Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Endocrine System Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Endocrine System Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Endocrine System Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Endocrine System Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Endocrine System Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine System Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Endocrine System Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Endocrine System Drugs Sales by Region (2019-2024) & (K Pcs)
Table 18. Global Endocrine System Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Endocrine System Drugs Sales by Region (2025-2030) & (K Pcs)
Table 20. Global Endocrine System Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Endocrine System Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Endocrine System Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Endocrine System Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Endocrine System Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Endocrine System Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Endocrine System Drugs Sales by Country (2019-2024) & (K Pcs)
Table 27. North America Endocrine System Drugs Sales by Country (2025-2030) & (K Pcs)
Table 28. North America Endocrine System Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Endocrine System Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Endocrine System Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Endocrine System Drugs Sales by Country (2019-2024) & (K Pcs)
Table 32. Europe Endocrine System Drugs Sales by Country (2025-2030) & (K Pcs)
Table 33. Europe Endocrine System Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Endocrine System Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Endocrine System Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Endocrine System Drugs Sales by Region (2019-2024) & (K Pcs)
Table 37. Asia Pacific Endocrine System Drugs Sales by Region (2025-2030) & (K Pcs)
Table 38. Asia Pacific Endocrine System Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Endocrine System Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Endocrine System Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Endocrine System Drugs Sales by Country (2019-2024) & (K Pcs)
Table 42. Latin America Endocrine System Drugs Sales by Country (2025-2030) & (K Pcs)
Table 43. Latin America Endocrine System Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Endocrine System Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Endocrine System Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Endocrine System Drugs Sales by Country (2019-2024) & (K Pcs)
Table 47. Middle East & Africa Endocrine System Drugs Sales by Country (2025-2030) & (K Pcs)
Table 48. Middle East & Africa Endocrine System Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Endocrine System Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Endocrine System Drugs Sales (K Pcs) by Type (2019-2024)
Table 51. Global Endocrine System Drugs Sales (K Pcs) by Type (2025-2030)
Table 52. Global Endocrine System Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Endocrine System Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Endocrine System Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Endocrine System Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Endocrine System Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Endocrine System Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Endocrine System Drugs Price (USD/Pcs) by Type (2019-2024)
Table 59. Global Endocrine System Drugs Price (USD/Pcs) by Type (2025-2030)
Table 60. Global Endocrine System Drugs Sales (K Pcs) by Application (2019-2024)
Table 61. Global Endocrine System Drugs Sales (K Pcs) by Application (2025-2030)
Table 62. Global Endocrine System Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Endocrine System Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Endocrine System Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Endocrine System Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Endocrine System Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Endocrine System Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Endocrine System Drugs Price (USD/Pcs) by Application (2019-2024)
Table 69. Global Endocrine System Drugs Price (USD/Pcs) by Application (2025-2030)
Table 70. Novo Nordisk Corporation Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 73. Novo Nordisk Endocrine System Drugs Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 78. Sanofi Endocrine System Drugs Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. Merck Endocrine System Drugs Product
Table 84. Merck Recent Developments/Updates
Table 85. Eli Lilly Corporation Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. Eli Lilly Endocrine System Drugs Product
Table 89. Eli Lilly Recent Developments/Updates
Table 90. AstraZeneca Corporation Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. AstraZeneca Endocrine System Drugs Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. AbbVie Corporation Information
Table 96. AbbVie Description and Business Overview
Table 97. AbbVie Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. AbbVie Endocrine System Drugs Product
Table 99. AbbVie Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Endocrine System Drugs Distributors List
Table 103. Endocrine System Drugs Customers List
Table 104. Endocrine System Drugs Market Trends
Table 105. Endocrine System Drugs Market Drivers
Table 106. Endocrine System Drugs Market Challenges
Table 107. Endocrine System Drugs Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Endocrine System Drugs
Figure 2. Global Endocrine System Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Endocrine System Drugs Market Share by Type in 2023 & 2030
Figure 4. Diabetes Drug Product Picture
Figure 5. Human Growth Hormones Product Picture
Figure 6. Thyroid Hormone Disorder Drugs Product Picture
Figure 7. Others Product Picture
Figure 8. Global Endocrine System Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Endocrine System Drugs Market Share by Application in 2023 & 2030
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Medical Center
Figure 13. Others
Figure 14. Global Endocrine System Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Endocrine System Drugs Market Size (2019-2030) & (US$ Million)
Figure 16. Global Endocrine System Drugs Sales (2019-2030) & (K Pcs)
Figure 17. Global Endocrine System Drugs Average Price (USD/Pcs) & (2019-2030)
Figure 18. Endocrine System Drugs Report Years Considered
Figure 19. Endocrine System Drugs Sales Share by Manufacturers in 2023
Figure 20. Global Endocrine System Drugs Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Endocrine System Drugs Players: Market Share by Revenue in 2023
Figure 22. Endocrine System Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Endocrine System Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Endocrine System Drugs Sales Market Share by Country (2019-2030)
Figure 25. North America Endocrine System Drugs Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Endocrine System Drugs Sales Market Share by Country (2019-2030)
Figure 29. Europe Endocrine System Drugs Revenue Market Share by Country (2019-2030)
Figure 30. Germany Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Endocrine System Drugs Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Endocrine System Drugs Revenue Market Share by Region (2019-2030)
Figure 37. China Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Endocrine System Drugs Sales Market Share by Country (2019-2030)
Figure 48. Latin America Endocrine System Drugs Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Endocrine System Drugs Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Endocrine System Drugs Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.A.E Endocrine System Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Endocrine System Drugs by Type (2019-2030)
Figure 58. Global Revenue Market Share of Endocrine System Drugs by Type (2019-2030)
Figure 59. Global Endocrine System Drugs Price (USD/Pcs) by Type (2019-2030)
Figure 60. Global Sales Market Share of Endocrine System Drugs by Application (2019-2030)
Figure 61. Global Revenue Market Share of Endocrine System Drugs by Application (2019-2030)
Figure 62. Global Endocrine System Drugs Price (USD/Pcs) by Application (2019-2030)
Figure 63. Endocrine System Drugs Value Chain
Figure 64. Endocrine System Drugs Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
